0001193125-20-018422.txt : 20200129 0001193125-20-018422.hdr.sgml : 20200129 20200129161615 ACCESSION NUMBER: 0001193125-20-018422 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200126 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20200129 DATE AS OF CHANGE: 20200129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 20558332 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 8-K 1 d844371d8k.htm 8-K 8-K
00-0000000 false 0001674416 0001674416 2020-01-26 2020-01-26

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 26, 2020

 

CRISPR THERAPEUTICS AG

(Exact name of Registrant as Specified in Its Charter)

 

Switzerland

  

001-37923

  

Not Applicable

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

Baarerstrasse 14

6300 Zug, Switzerland

  

Not Applicable

(Address of Principal Executive Offices)

  

(Zip Code)

Registrant’s Telephone Number, Including Area Code: +41 (0)41 561 32 77

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Common Shares, CHF 0.03 par value

  

CRSP

  

NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of January 26, 2020, Lawrence O. Klein, Ph.D., the Chief Business Officer of CRISPR Therapeutics AG (the “Company”), was also appointed to serve as the Company’s Chief Operating Officer.

Biographical information for Dr. Klein can be found on page 20 of the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 30, 2019 and is hereby incorporated by reference herein. The Company has not entered into any new or amended compensation arrangements with Dr. Klein in connection with his new role at this time.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CRISPR THERAPEUTICS AG

             

Date: January 29, 2020

 

 

By:

 

/s/ Samarth Kulkarni

 

 

 

Samarth Kulkarni, Ph.D.

 

 

 

Chief Executive Officer

EX-101.SCH 2 crsp-20200126.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 crsp-20200126_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Tax Identification Number Entity Tax Identification Number Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 crsp-20200126_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d844371d8k.htm crsp-20200126.xsd crsp-20200126_lab.xml crsp-20200126_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false JSON 6 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d844371d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d844371d8k.htm" ] }, "labelLink": { "local": [ "crsp-20200126_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "crsp-20200126_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "crsp-20200126.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "crsp", "nsuri": "http://www.crisprtx.com/20200126", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "body", "html" ], "baseRef": "d844371d8k.htm", "contextRef": "duration_2020-01-26_to_2020-01-26", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "body", "html" ], "baseRef": "d844371d8k.htm", "contextRef": "duration_2020-01-26_to_2020-01-26", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.crisprtx.com//20200126/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 d844371d8k_htm.xml IDEA: XBRL DOCUMENT 0001674416 2020-01-26 2020-01-26 00-0000000 false 0001674416 8-K 2020-01-26 CRISPR THERAPEUTICS AG V8 001-37923 Baarerstrasse 14 6300 Zug CH 41 (0)41 561 32 77 false false false false Common Shares, CHF 0.03 par value CRSP NASDAQ false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Document and Entity Information
Jan. 26, 2020
Cover [Abstract]  
Entity Tax Identification Number 00-0000000
Amendment Flag false
Entity Central Index Key 0001674416
Document Type 8-K
Document Period End Date Jan. 26, 2020
Entity Registrant Name CRISPR THERAPEUTICS AG
Entity Incorporation State Country Code V8
Entity File Number 001-37923
Entity Address, Address Line One Baarerstrasse 14
Entity Address, Postal Zip Code 6300
Entity Address, City or Town Zug
Entity Address, Country CH
City Area Code 41 (0)41
Local Phone Number 561 32 77
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Shares, CHF 0.03 par value
Trading Symbol CRSP
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 13 0001193125-20-018422-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-018422-xbrl.zip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end